Statement: the primary trial participants are given intravenous and inhalation medication, while secondary trial patients receive treatment through injectable medications.
Primary_evidence: INTERVENTION 1:    Positron Emission Mammography   Positron Emission Mammography: Patients will receive bilateral (both sides) breast and axillary PEM scans, bilateral mammography, DCE-MRI, US of the breast and axilla (the side of the affected breast), and ultrasound guided biopsy of axillary lymph node if suspicious. Various PEM views will be performed on both your breast and axilla (underarm).
Secondary_evidence: INTERVENTION 1:    Exemestane   Patients receive oral exemestane (25 mg) once daily for 5 years.   exemestane: Given orally INTERVENTION 2:    Anastrozole   Patients receive oral anastrozole (1 mg) once daily for 5 years.   anastrozole: Given orally